Mar 01, 2019 / Chapters Chapter 3: Hospital inpatient and outpatient services (March 2019 report) Research Areas: Hospitals, Medicare Spending and Financing, Quality
Mar 01, 2019 / Chapters Chapter 16: Mandated report: Opioids and alternatives in hospital settings—Payments, incentives, and Medicare data (March 2019 report) Research Areas: Drugs, Devices, and Tests, Hospitals
Mar 01, 2019 / Chapters Executive summary (March 2019 report) Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jan 18, 2019 / Presentations Future policy directions to address Medicare prescription drug spending Research Areas: Drugs, Devices, and Tests
Jan 17, 2019 / Presentations Opioids and alternatives in hospital settings: Payments, incentives, and Medicare data Research Areas: Drugs, Devices, and Tests, Hospitals
Jan 16, 2019 / Comment Letters MedPAC comment on CMS’s proposed rule on modernizing Part D and Medicare Advantage to lower drug prices and reduce OOP expenses Research Areas: Delivery System Reforms, Drugs, Devices, and Tests, Private Plans
Dec 18, 2018 / Comment Letters MedPAC comment on CMS’s ANPRM on the International Pricing Index Model for Medicare Part B drugs Research Areas: Delivery System Reforms, Drugs, Devices, and Tests
Nov 28, 2018 / Comment Letters MedPAC comment on CMS’s proposed rule on requiring drug pricing transparency Research Areas: Delivery System Reforms, Drugs, Devices, and Tests
Oct 04, 2018 / Presentations Opioids and alternatives in hospital settings: Payments, incentives, and Medicare data Research Areas: Drugs, Devices, and Tests, Hospitals
Sep 17, 2018 / Comment Letters MedPAC comment on CMS’s proposed rule on hospital outpatient and ambulatory surgical center payment systems for CY 2019 Research Areas: Ambulatory Care Settings, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Quality